You are here Home Vaccines Vaccines Avaxim Details for Avaxim (hepatitis A) vaccine and its components. Listen Print Share Twitter Facebook Email Recently added This page was added on 04 June 2018. Updates made This page was updated on [date-counter-updated-date]. View history of updates Sponsor Sanofi-Aventis Australia Administration route Intramuscular injection Vaccine group Monovalent vaccines Description: Registered for use in people aged ≥2 years. Each 0.5 mL monodose pre-filled syringe contains: 160 antigen units of inactivated hepatitis A virus (GBM strain) 0.3 mg aluminium as aluminium hydroxide 2.5 µL phenoxyethanol 12.5 µg formaldehyde ≤2.5 µg neomycin <50 ng bovine serum albumin traces of polysorbate 80 For Product Information and Consumer Medicine Information about Avaxim visit the Therapeutic Goods Administration website. Additional vaccine information For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s. Related diseases Hepatitis A Page history Last updated 4 June 2018 Last reviewed 4 June 2018 Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank
